|
1
|
Ma O, Cai WW, Zender L, Dayaram T, Shen J,
Herron AJ, Lowe SW, Man TK, Lau CC and Donehower LA: MMP13, Birc2
(cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate
with p53 deficiency in mouse osteosarcoma progression. Cancer Res.
69:2559–2567. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Janeway KA and Grier HE: Sequelae of
osteosarcoma medical therapy: a review of rare acute toxicities and
late effects. Lancet Oncol. 11:670–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caudill JS and Arndt CA: Diagnosis and
management of bone malignancy in adolescence. Adolesc Med State Art
Rev. 18:62–78. 2007.
|
|
4
|
Bacci G, Rocca M, Salone M, Balladelli A,
Ferrari S, Palmerini E, Forni C and Briccoli A: High grade
osteosarcoma of the extremities with lung metastases at
presentation: treatment with neoadjuvant chemotherapy and
simultaneous resection of primary and metastatic lesions. J Surg
Oncol. 98:415–420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: an analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar
|
|
6
|
Errani C, Longhi A, Rossi G, Rimondi E,
Biazzo A, Toscano A, Alì N, Ruggieri P, Alberghini M, Picci P, et
al: Palliative therapy for osteosarcoma. Expert Rev Anticancer
Ther. 11:217–227. 2011. View Article : Google Scholar
|
|
7
|
Denning GM: IL-4 and IFN-gamma
synergistically increase total polymeric IgA receptor levels in
human intestinal epithelial cells. Role of protein tyrosine
kinases. J Immunol. 156:4807–4814. 1996.
|
|
8
|
Kvale D, Løvhaug D, Sollid LM and
Brandtzaeg P: Tumor necrosis factor-alpha up-regulates expression
of secretory component, the epithelial receptor for polymeric Ig. J
Immunol. 140:3086–3089. 1988.PubMed/NCBI
|
|
9
|
Rojas R and Apodaca G: Immunoglobulin
transport across polarized epithelial cells. Nat Rev Mol Cell Biol.
3:944–955. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaetzel CS: The polymeric immunoglobulin
receptor: bridging innate and adaptive immune responses at mucosal
surfaces. Immunol Rev. 206:83–99. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Poger ME, Hirsch BR and Lamm ME: Synthesis
of secretory component by colonic neoplasms. Am J Pathol.
82:327–338. 1976.PubMed/NCBI
|
|
12
|
Harris JP, Caleb MH and South MA:
Secretory component in human mammary carcinoma. Cancer Res.
35:1861–1864. 1975.PubMed/NCBI
|
|
13
|
Harris JP and South MA: Secretory
component: a glandular epithelial cell marker. Am J Pathol.
105:47–53. 1981.PubMed/NCBI
|
|
14
|
DeSouza LV, Krakovska O, Darfler MM,
Krizman DB, Romaschin AD, Colgan TJ and Siu KW: mTRAQ-based
quantification of potential endometrial carcinoma biomarkers from
archived formalin-fixed paraffin-embedded tissues. Proteomics.
10:3108–3116. 2010. View Article : Google Scholar
|
|
15
|
DeSouza LV, Romaschin AD, Colgan TJ and
Siu KW: Absolute quantification of potential cancer markers in
clinical tissue homogenates using multiple reaction monitoring on a
hybrid triple quadrupole/linear ion trap tandem mass spectrometer.
Anal Chem. 81:3462–3470. 2009. View Article : Google Scholar
|
|
16
|
Rossel M, Billerey C, Bittard H, Ksiazek
P, Alber D, Revillard JP and Vuitton DA: Alterations in polymeric
immunoglobulin receptor expression and secretory component levels
in bladder carcinoma. Urol Res. 19:361–366. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rossel M, Seilles E, Voigt JJ, Vuitton D,
Legait N and Revillard JP: Polymeric Ig receptor expression in
hepatocellular carcinoma. Eur J Cancer. 28A:1120–1124. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ai J, Tang Q, Wu Y, Xu Y, Feng T, Zhou R,
Chen Y, Gao X, Zhu Q, Yue X, et al: The role of polymeric
immunoglobulin receptor in inflammation-induced tumor metastasis of
human hepatocellular carcinoma. J Natl Cancer Inst. 103:1696–1712.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao T, Ying W, Li L, Hu Z, Ma Y, Jiao L,
Ma J, Cai Y, Lin D, Guo S, et al: An approach to studying lung
cancer-related proteins in human blood. Mol Cell Proteomics.
4:1480–1486. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rossel M, Brambilla E, Billaud M, Vuitton
DA, Blanc-Jouvan F, Biichle S and Revillard JP: Nonspecific
increased serum levels of secretory component in lung tumors:
relationship to the gene expression of the transmembrane receptor
form. Am J Respir Cell Mol Biol. 9:341–346. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Makawita S, Smith C, Batruch I, Zheng Y,
Rückert F, Grützmann R, Pilarsky C, Gallinger S and Diamandis EP:
Integrated proteomic profiling of cell line conditioned media and
pancreatic juice for the identification of pancreatic cancer
biomarkers. Mol Cell Proteomics. 10:M111.0085992011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kvale D, Norstein J, Meling GI, Børmer OP,
Brandtzaeg P, Langmark F and Rognum TO: Circulating secretory
component in relation to early diagnosis and treatment of liver
metastasis from colorectal carcinomas. J Clin Pathol. 45:568–571.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. 1980.
Clin Orthop Relat Res. 415:4–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bruno ME and Kaetzel CS: Long-term
exposure of the HT-29 human intestinal epithelial cell line to TNF
causes sustained up-regulation of the polymeric Ig receptor and
proinflammatory genes through transcriptional and
posttranscriptional mechanisms. J Immunol. 174:7278–7284. 2005.
View Article : Google Scholar
|
|
25
|
Khattar NH, Lele SM and Kaetzel CS:
Down-regulation of the polymeric immunoglobulin receptor in
non-small cell lung carcinoma: correlation with dysregulated
expression of the transcription factors USF and AP2. J Biomed Sci.
12:65–77. 2005. View Article : Google Scholar
|
|
26
|
Laverdiere C, Hoang BH, Yang R, Sowers R,
Qin J, Meyers PA, Huvos AG, Healey JH and Gorlick R: Messenger RNA
expression levels of CXCR4 correlate with metastatic behavior and
outcome in patients with osteosarcoma. Clin Cancer Res.
11:2561–2567. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Urakawa H, Nishida Y, Nakashima H,
Shimoyama Y, Nakamura S and Ishiguro N: Prognostic value of
indoleamine 2,3-dioxygenase expression in high grade osteosarcoma.
Clin Exp Metastasis. 26:1005–1012. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eccles SA and Welch DR: Metastasis: recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mestecky J and McGhee JR: Immunoglobulin A
(IgA): molecular and cellular interactions involved in IgA
biosynthesis and immune response. Adv Immunol. 40:153–245. 1987.
View Article : Google Scholar : PubMed/NCBI
|
